Japanese Encephalitis Virus and Other Closely Related Clinically Important Orthoflaviviruses—a Persistent Threat to Public and Animal Health
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "General Virology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 565
Special Issue Editor
Interests: swine virus; flavivirus; JEV
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mosquito-borne viruses represent a dynamic and expanding threat to public and animal health, fueled by ecological disruption and globalization. Japanese encephalitis virus (JEV), a mosquito-borne orthoflavivirus, remains a significant global zoonotic pathogen which has profound implications for human and animal health. As the causative agent of Japanese encephalitis (JE), JEV induces severe neurological disease in humans and reproductive disorders in swine, its primary amplifying host.
In humans, JEV infection causes acute viral encephalitis with high mortality rates (20–30%) and frequent neurological complications, affecting 30–50% of survivors. The virus breaches the blood–brain barrier (BBB) through mechanisms involving receptor-mediated transcytosis, subsequently infiltrating the central nervous system (CNS). This invasion triggers neuroinflammatory cascades characterized by microglial activation, cytokine storms, and neuronal apoptosis, ultimately leading to fatal outcomes. Porcine infections manifest as reproductive failure clusters featuring stillbirths, mummified fetuses, and neonatal mortality, causing annual economic losses exceeding USD 500 million in endemic regions. Swine serve as critical amplification hosts due to sustained viremia and persistent tonsillar infection, maintaining viral transmission within mosquito–swine–human enzootic cycles.
Mosquito-borne viruses have imposed a huge burden on public health. JEV endemicity spans tropical and subtropical Asia-Pacific regions, exposing approximately 3 billion people to infection risk according to WHO estimates (World Health Organization, 2016. Japanese encephalitis vaccines: WHO position paper. Weekly Epidemiological Record 91, 69–88). Surveillance data from 2018–2022 indicate a 12% annual increase in human cases, attributed to vaccine accessibility gaps, the thermal instability of conventional vaccines, and climate-mediated expansion of Culex vector habitats. Domestic pig populations in rural ecosystems function as epidemiological sentinels, amplifying JEV transmission through mosquito vectors. Climate modeling predicts a 17-23% northward expansion of JEV transmission zones by 2040, threatening previously unaffected temperate regions.
This Research Topic seeks to advance JEV control strategies through multidisciplinary investigations of viral pathogenesis and transmission dynamics. We encourage submissions addressing, but not limited to, the following areas:
- Molecular mechanisms of JEV adaptation through experimental evolution studies;
- Genomic surveillance of natural JEV isolates from arthropod vectors and vertebrate hosts;
- Host–pathogen interactions governing JEV entry and systemic spread;
- Ecological determinants of JEV transmission in vector–host systems;
- Computational modeling of JEV infection networks and outbreak prediction;
- Next-generation vaccine platforms and broad-spectrum antiviral development.
Dr. Ke Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Japanese encephalitis virus
- mosquito-borne
- orthoflaviviruses
- public and animal health
- transmission
- infection
- host
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
